Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-l

S. Mallick, R. Patil, R. Gyanchandani, S. Pawar, V. Palve, S. Kannan, K. A. Pathak, M. Choudhary, T. R. Teni

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Expression of Bcl-2 family proteins in tumours can modulate apoptosis, influencing tumour behaviour and treatment. To investigate their role in oral tumourigenesis, nine Bcl-2 family transcripts were examined in three oral cell lines and 25 oral tumours, using ribonuclease protection assay. Since Mcl-1 mRNA was elevated in these samples, Mcl-1 splice variants were assessed by RT-PCR and Mcl-1 protein was studied in normal, premalignant and malignant oral tissues and cell lines, by immunohistochemistry and/or immunoblotting. The cell lines exhibited significantly higher levels of 7/9 Bcl-2 family transcripts as compared to those in normal tongue, and significantly higher (p = 0.030, p = 0.004) anti-apoptotic versus pro-apoptotic transcripts. Elevated Mcl-1 mRJNA was observed in 11/25 (44%) tumours as compared to normal tissues with a fiveto ten-fold higher expression of full-length anti-apoptotic Mcl-1 transcript versus the pro-apoptotic short isoform. Strong cytoplasmic Mcl-1 immunoreactivity was detected predominantly in differentiated epithelia in 27/33 (82%) oral tumours, 18/20 (90%) leukoplakia, 25/30 (83%) submucous fibrosis and 3/3 oral cell lines, with weak staining in 8/15 (53%) normal mucosa samples. Mcl-1 positivity in malignant and premalignant tissues was comparable but significantly higher (p < 0.01) than that in normal mucosa. The expression of bcl-2 family genes, including Mcl-1 in tumours, did not correlate significantly with clinicopathological parameters. This is the first report delineating the in vivo expression patterns of Mcl-1 protein and Mcl-1 transcripts in oral cancers and premalignant lesions. The observed imbalance between expression of anti-apoptotic and pro-apoptotic Bcl-2 family genes may promote survival in the oral cell lines. Since the majority of oral tumours associated with tobacco-chewing evolve from premalignant lesions, the sustained expression of full-length anti-apoptotic Mcl-1 protein in these tissues suggests an important role for Mcl-1, early in oral cancer pathogenesis in protecting cells from apoptosis via neutralization of pro-apoptotic members and could be a potential therapeutic target for oral cancers.

Original languageEnglish (US)
Pages (from-to)398-407
Number of pages10
JournalJournal of Pathology
Volume217
Issue number3
DOIs
StatePublished - Feb 1 2009
Externally publishedYes

Fingerprint

Mouth Neoplasms
Cell Line
Neoplasms
bcl-2 Genes
Mucous Membrane
Proteins
Apoptosis
Leukoplakia
Tobacco Use
Ribonucleases
Tongue
Immunoblotting
Protein Isoforms
Fibrosis
Epithelium
Immunohistochemistry
Staining and Labeling
Polymerase Chain Reaction
Messenger RNA
Therapeutics

Keywords

  • Apoptosis
  • Bcl-2 family members
  • Mcl-1
  • Oral cancer
  • Oral cavity
  • Oral cell lines
  • Oral lesions
  • Ribonuclease protection assay

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-l. / Mallick, S.; Patil, R.; Gyanchandani, R.; Pawar, S.; Palve, V.; Kannan, S.; Pathak, K. A.; Choudhary, M.; Teni, T. R.

In: Journal of Pathology, Vol. 217, No. 3, 01.02.2009, p. 398-407.

Research output: Contribution to journalArticle

Mallick, S, Patil, R, Gyanchandani, R, Pawar, S, Palve, V, Kannan, S, Pathak, KA, Choudhary, M & Teni, TR 2009, 'Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-l', Journal of Pathology, vol. 217, no. 3, pp. 398-407. https://doi.org/10.1002/path.2459
Mallick, S. ; Patil, R. ; Gyanchandani, R. ; Pawar, S. ; Palve, V. ; Kannan, S. ; Pathak, K. A. ; Choudhary, M. ; Teni, T. R. / Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-l. In: Journal of Pathology. 2009 ; Vol. 217, No. 3. pp. 398-407.
@article{9c20a3c421b34c649775a479d2a41a8e,
title = "Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-l",
abstract = "Expression of Bcl-2 family proteins in tumours can modulate apoptosis, influencing tumour behaviour and treatment. To investigate their role in oral tumourigenesis, nine Bcl-2 family transcripts were examined in three oral cell lines and 25 oral tumours, using ribonuclease protection assay. Since Mcl-1 mRNA was elevated in these samples, Mcl-1 splice variants were assessed by RT-PCR and Mcl-1 protein was studied in normal, premalignant and malignant oral tissues and cell lines, by immunohistochemistry and/or immunoblotting. The cell lines exhibited significantly higher levels of 7/9 Bcl-2 family transcripts as compared to those in normal tongue, and significantly higher (p = 0.030, p = 0.004) anti-apoptotic versus pro-apoptotic transcripts. Elevated Mcl-1 mRJNA was observed in 11/25 (44{\%}) tumours as compared to normal tissues with a fiveto ten-fold higher expression of full-length anti-apoptotic Mcl-1 transcript versus the pro-apoptotic short isoform. Strong cytoplasmic Mcl-1 immunoreactivity was detected predominantly in differentiated epithelia in 27/33 (82{\%}) oral tumours, 18/20 (90{\%}) leukoplakia, 25/30 (83{\%}) submucous fibrosis and 3/3 oral cell lines, with weak staining in 8/15 (53{\%}) normal mucosa samples. Mcl-1 positivity in malignant and premalignant tissues was comparable but significantly higher (p < 0.01) than that in normal mucosa. The expression of bcl-2 family genes, including Mcl-1 in tumours, did not correlate significantly with clinicopathological parameters. This is the first report delineating the in vivo expression patterns of Mcl-1 protein and Mcl-1 transcripts in oral cancers and premalignant lesions. The observed imbalance between expression of anti-apoptotic and pro-apoptotic Bcl-2 family genes may promote survival in the oral cell lines. Since the majority of oral tumours associated with tobacco-chewing evolve from premalignant lesions, the sustained expression of full-length anti-apoptotic Mcl-1 protein in these tissues suggests an important role for Mcl-1, early in oral cancer pathogenesis in protecting cells from apoptosis via neutralization of pro-apoptotic members and could be a potential therapeutic target for oral cancers.",
keywords = "Apoptosis, Bcl-2 family members, Mcl-1, Oral cancer, Oral cavity, Oral cell lines, Oral lesions, Ribonuclease protection assay",
author = "S. Mallick and R. Patil and R. Gyanchandani and S. Pawar and V. Palve and S. Kannan and Pathak, {K. A.} and M. Choudhary and Teni, {T. R.}",
year = "2009",
month = "2",
day = "1",
doi = "10.1002/path.2459",
language = "English (US)",
volume = "217",
pages = "398--407",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-l

AU - Mallick, S.

AU - Patil, R.

AU - Gyanchandani, R.

AU - Pawar, S.

AU - Palve, V.

AU - Kannan, S.

AU - Pathak, K. A.

AU - Choudhary, M.

AU - Teni, T. R.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Expression of Bcl-2 family proteins in tumours can modulate apoptosis, influencing tumour behaviour and treatment. To investigate their role in oral tumourigenesis, nine Bcl-2 family transcripts were examined in three oral cell lines and 25 oral tumours, using ribonuclease protection assay. Since Mcl-1 mRNA was elevated in these samples, Mcl-1 splice variants were assessed by RT-PCR and Mcl-1 protein was studied in normal, premalignant and malignant oral tissues and cell lines, by immunohistochemistry and/or immunoblotting. The cell lines exhibited significantly higher levels of 7/9 Bcl-2 family transcripts as compared to those in normal tongue, and significantly higher (p = 0.030, p = 0.004) anti-apoptotic versus pro-apoptotic transcripts. Elevated Mcl-1 mRJNA was observed in 11/25 (44%) tumours as compared to normal tissues with a fiveto ten-fold higher expression of full-length anti-apoptotic Mcl-1 transcript versus the pro-apoptotic short isoform. Strong cytoplasmic Mcl-1 immunoreactivity was detected predominantly in differentiated epithelia in 27/33 (82%) oral tumours, 18/20 (90%) leukoplakia, 25/30 (83%) submucous fibrosis and 3/3 oral cell lines, with weak staining in 8/15 (53%) normal mucosa samples. Mcl-1 positivity in malignant and premalignant tissues was comparable but significantly higher (p < 0.01) than that in normal mucosa. The expression of bcl-2 family genes, including Mcl-1 in tumours, did not correlate significantly with clinicopathological parameters. This is the first report delineating the in vivo expression patterns of Mcl-1 protein and Mcl-1 transcripts in oral cancers and premalignant lesions. The observed imbalance between expression of anti-apoptotic and pro-apoptotic Bcl-2 family genes may promote survival in the oral cell lines. Since the majority of oral tumours associated with tobacco-chewing evolve from premalignant lesions, the sustained expression of full-length anti-apoptotic Mcl-1 protein in these tissues suggests an important role for Mcl-1, early in oral cancer pathogenesis in protecting cells from apoptosis via neutralization of pro-apoptotic members and could be a potential therapeutic target for oral cancers.

AB - Expression of Bcl-2 family proteins in tumours can modulate apoptosis, influencing tumour behaviour and treatment. To investigate their role in oral tumourigenesis, nine Bcl-2 family transcripts were examined in three oral cell lines and 25 oral tumours, using ribonuclease protection assay. Since Mcl-1 mRNA was elevated in these samples, Mcl-1 splice variants were assessed by RT-PCR and Mcl-1 protein was studied in normal, premalignant and malignant oral tissues and cell lines, by immunohistochemistry and/or immunoblotting. The cell lines exhibited significantly higher levels of 7/9 Bcl-2 family transcripts as compared to those in normal tongue, and significantly higher (p = 0.030, p = 0.004) anti-apoptotic versus pro-apoptotic transcripts. Elevated Mcl-1 mRJNA was observed in 11/25 (44%) tumours as compared to normal tissues with a fiveto ten-fold higher expression of full-length anti-apoptotic Mcl-1 transcript versus the pro-apoptotic short isoform. Strong cytoplasmic Mcl-1 immunoreactivity was detected predominantly in differentiated epithelia in 27/33 (82%) oral tumours, 18/20 (90%) leukoplakia, 25/30 (83%) submucous fibrosis and 3/3 oral cell lines, with weak staining in 8/15 (53%) normal mucosa samples. Mcl-1 positivity in malignant and premalignant tissues was comparable but significantly higher (p < 0.01) than that in normal mucosa. The expression of bcl-2 family genes, including Mcl-1 in tumours, did not correlate significantly with clinicopathological parameters. This is the first report delineating the in vivo expression patterns of Mcl-1 protein and Mcl-1 transcripts in oral cancers and premalignant lesions. The observed imbalance between expression of anti-apoptotic and pro-apoptotic Bcl-2 family genes may promote survival in the oral cell lines. Since the majority of oral tumours associated with tobacco-chewing evolve from premalignant lesions, the sustained expression of full-length anti-apoptotic Mcl-1 protein in these tissues suggests an important role for Mcl-1, early in oral cancer pathogenesis in protecting cells from apoptosis via neutralization of pro-apoptotic members and could be a potential therapeutic target for oral cancers.

KW - Apoptosis

KW - Bcl-2 family members

KW - Mcl-1

KW - Oral cancer

KW - Oral cavity

KW - Oral cell lines

KW - Oral lesions

KW - Ribonuclease protection assay

UR - http://www.scopus.com/inward/record.url?scp=60549100502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549100502&partnerID=8YFLogxK

U2 - 10.1002/path.2459

DO - 10.1002/path.2459

M3 - Article

C2 - 19009587

AN - SCOPUS:60549100502

VL - 217

SP - 398

EP - 407

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 3

ER -